Advertisement

Topics

Stealth casts a wide net with experimental treatment for mitochondrial diseases

13:55 EDT 30 Jun 2017 | MedCity News

Stealth is moving towards Phase 3 trials in primary mitochondrial myopathy – a common denominator in many mitochondrial diseases – with an emphasis on improving patients’ quality of life.

Original Article: Stealth casts a wide net with experimental treatment for mitochondrial diseases

NEXT ARTICLE

More From BioPortfolio on "Stealth casts a wide net with experimental treatment for mitochondrial diseases"

Advertisement
Quick Search
Advertisement
Advertisement